Bristol-Myers Squibb Company (JOBS) Settles FTC Probe

(Reuters) - Bristol-Myers Squibb Co agreed to pay $2.1 million to settle a probe by the U.S. Federal Trade Commission into its negotiations in to delay the launch of a generic version of its blockbuster drug Plavix, the Wall Street Journal said.